Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
EG

Eric Gould Gundersen — 13 Patents

Pfizer: 10 patents #491 of 5,153Top 10%
APAmerimas Home Products: 2 patents #313 of 715Top 45%
Plainsboro, NJ: #187 of 1,381 inventorsTop 15%
New Jersey: #6,737 of 69,400 inventorsTop 10%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
Eric Gould Gundersen has been granted 13 US patents while listed as an inventor at Pfizer. The first was granted in 1998 and the most recent in December 2009. Eric Gould Gundersen ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list Eric Gould Gundersen in Plainsboro, NJ, US.

Patents per Year

Patents granted per year, 1998 to 2009Bar chart with a peak of 3 patents in 2008.peak 31998: 2 patents19982001: 1 patents20012002: 1 patents20022004: 2 patents20042005: 1 patents20052006: 1 patents20062008: 3 patents20082009: 2 patents2009

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7629377 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) David LeRoy Crandall, Scott Mayer, Hassan Mahmoud Elokdah 2009-12-08
7582773 Substituted phenyl indoles 2009-09-01 $58,688,000
7420083 Substituted aryloximes Lisa Marie Havran, John A. Butera, Hassan Mahmoud Elokdah, Douglas John Jenkins 2008-09-02 $56,812,000
7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) Scott Mayer, Hassan Mahmoud Elokdah, David LeRoy Crandall 2008-04-01 $61,136,000
7342039 Substituted indole oximes Lisa Marie Havran, John A. Butera, Hassan Mahmoud Elokdah, Douglas John Jenkins 2008-03-11 $57,502,000
7008636 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Lisa Marie Havran +4 more 2006-03-07 $92,854,000
6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) Scott Mayer, Hassan Mahmoud Elokdah, David LeRoy Crandall 2005-09-06 $70,874,000
6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) Scott Mayer, Hassan Mahmoud Elokdah, David LeRoy Crandall 2004-10-05 $38,333,000
6765021 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Lisa Marie Havran +4 more 2004-07-20 $287,757,000
6451827 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Lisa Marie Havran +4 more 2002-09-17 $105,113,000
6214877 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia John A. Butera, Craig E. Caufield, Russell Graceffa, Alexander Greenfield, Lisa Marie Havran +4 more 2001-04-10
5780505 Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones Madelene M. Antane, David R. Herbst, Geraldine Ruth McFarlane, Bradford H. Hirth, Dominick Anthony Quagliato +2 more 1998-07-14 $133,556,000
5763474 Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones David R. Herbst, Madelene M. Antane, Geraldine Ruth McFarlane, Bradford H. Hirth, Dominick Anthony Quagliato +2 more 1998-06-09 $162,953,000